[Development of BMP-related drugs].
Kawate
Hisaya
H
Department of Geriatric Medicine, Graduate School of Medical Sciences, Kyushu University.
Ohnaka
Keizo
K
Takayanagi
Ryoichi
R
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism*; D002986:Clinical Trials as Topic; D015195:Drug Design; D050723:Fractures, Bone / Q000517:prevention & control; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D047908:Intracellular Signaling Peptides and Proteins; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use; D010006:Osteoblasts / Q000378:metabolism; D010012:Osteogenesis / Q000187:drug effects / Q000235:genetics; D010024:Osteoporosis / Q000188:drug therapy*; D061988:Proteasome Inhibitors; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism*; D020741:rho GTP-Binding Proteins / Q000037:antagonists & inhibitors; D054460:rho-Associated Kinases
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D009842:Oligopeptides; D061988:Proteasome Inhibitors; D016212:Transforming Growth Factor beta; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases; D020741:rho GTP-Binding Proteins; C078846:epoxomicin